Novo Nordisk awarded Gold Class distinction by Sustainability Asset Management
In its Sustainability Yearbook 2011, Sustainability Asset Management (SAM) has awarded Novo Nordisk the Gold Class distinction, recognising the company's strong performance on economic, environmental, and social issues that focus on long-term value creation. Novo Nordisk was one of four companies in the pharmaceutical sector to have received the Gold Class distinction.
"The Gold Class distinction is a welcome confirmation of the value of our Triple Bottom Line business principle," says Susanne Stormer, Vice President of Global TBL Management, Novo Nordisk.
In September 2010, Novo Nordisk kept its position in the top of the Dow Jones Sustainability Indexes with a score of 84 out of 100 points. The top score in the pharmaceutical sector was 85. To qualify for the SAM Gold Class distinction, Novo Nordisk's 2010 Dow Jones Sustainability Indexes score was within 5% of the pharmaceutical sector leader.
Read more about Novo Nordisk's performance on the 2010 Dow Jones Sustainability Indexes.
In addition to recognising top performing companies, the Sustainability Yearbook 2011 outlines challenges facing the pharmaceutical sector, including research into diseases with little commercial potential, global patent protection, bioethics, and ethical issues related to drug testing and drug safety.
Read more about SAM's Sustainability Yearbook 2011.
Sustainable Asset Management (SAM) is an investment group focused exclusively on sustainability investing that provides asset managers with benchmarks to manage sustainability portfolios. SAM partners with Dow Jones Indexes and STOXX Limited to publish and license the globally recognized Dow Jones Sustainability Indexes (DJSI).